Healthcare provider profile · identity verified

James E Muntz, MD

Internal Medicine · HOUSTON, TX · NPI 1114935079

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	991	276
Levothyroxine Sodium	Levothyroxine Sodium	664	179
Losartan Potassium	Losartan Potassium	463	129
Metformin Hcl	Metformin Hcl	456	131
Amlodipine Besylate	Amlodipine Besylate	339	96
Ezetimibe	Ezetimibe	324	91
Rosuvastatin Calcium	Rosuvastatin Calcium	323	96
Azithromycin	Azithromycin	243	191
Prednisone	Prednisone	222	169
Lisinopril	Lisinopril	212	64
Simvastatin	Simvastatin	200	52
Tamsulosin Hcl	Tamsulosin Hcl	195	60
Zolpidem Tartrate	Zolpidem Tartrate	193	61
Escitalopram Oxalate	Escitalopram Oxalate	187	49
Gabapentin	Gabapentin	176	50
Allopurinol	Allopurinol	175	49
Montelukast Sodium	Montelukast Sodium	169	55
Ozempic	Semaglutide	164	30
Meloxicam	Meloxicam	163	51
Metoprolol Succinate	Metoprolol Succinate	157	42
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	156	51
Ramipril	Ramipril	153	39
Potassium Chloride	Potassium Chloride	152	44
Eliquis	Apixaban	151	26
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	141	33
Hydrochlorothiazide	Hydrochlorothiazide	138	40
Omeprazole	Omeprazole	137	33
Synthroid	Levothyroxine Sodium	137	33
Amoxicillin	Amoxicillin	132	116
Pantoprazole Sodium	Pantoprazole Sodium	132	39
Furosemide	Furosemide	127	34
Metformin Hcl Er	Metformin Hcl	126	32
Pravastatin Sodium	Pravastatin Sodium	121	34
Alprazolam	Alprazolam	116	27
Metoprolol Tartrate	Metoprolol Tartrate	112	35
Nifedipine Er	Nifedipine	112	31
Trazodone Hcl	Trazodone Hcl	107	28
Januvia	Sitagliptin Phosphate	95	24
Hydroxyzine Hcl	Hydroxyzine Hcl	88	23
Xarelto	Rivaroxaban	88	25
Atenolol	Atenolol	83	20
Sertraline Hcl	Sertraline Hcl	78	21
Valacyclovir	Valacyclovir Hcl	78	37
Ciprofloxacin Hcl	Ciprofloxacin Hcl	74	64
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	73	20
Testosterone	Testosterone	71	20
Mounjaro	Tirzepatide	68	suppressed
Bupropion Xl	Bupropion Hcl	63	13
Lovastatin	Lovastatin	62	15
Irbesartan	Irbesartan	60	14
Carvedilol	Carvedilol	59	11
Pregabalin	Pregabalin	59	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	57	11
Esomeprazole Magnesium	Esomeprazole Magnesium	56	20
Paxlovid	Nirmatrelvir/Ritonavir	55	55
Valsartan	Valsartan	54	15
Olmesartan Medoxomil	Olmesartan Medoxomil	51	16
Finasteride	Finasteride	50	16
Fluticasone Propionate	Fluticasone Propionate	49	15
Benazepril Hcl	Benazepril Hcl	48	12
Celecoxib	Celecoxib	48	19
Repaglinide	Repaglinide	46	12
Sumatriptan Succinate	Sumatriptan Succinate	43	suppressed
Nebivolol Hcl	Nebivolol Hcl	42	11
Dexamethasone	Dexamethasone	38	34
Donepezil Hcl	Donepezil Hcl	38	11
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Glimepiride	Glimepiride	38	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	13
Breo Ellipta	Fluticasone/Vilanterol	36	suppressed
Hydrocortisone	Hydrocortisone	36	11
Warfarin Sodium	Warfarin Sodium	36	11
Clopidogrel	Clopidogrel Bisulfate	35	14
Methylprednisolone	Methylprednisolone	35	33
Trulicity	Dulaglutide	33	suppressed
Duloxetine Hcl	Duloxetine Hcl	32	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	31	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	25
Propranolol Hcl	Propranolol Hcl	31	suppressed
Azelastine Hcl	Azelastine Hcl	30	11
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	30	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	30	suppressed
Livalo	Pitavastatin Calcium	30	11
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Niacin Er	Niacin	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Colchicine	Colchicine	24	11
Famotidine	Famotidine	24	suppressed
Levofloxacin	Levofloxacin	24	22
Pitavastatin Calcium	Pitavastatin Calcium	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	18
Oseltamivir Phosphate	Oseltamivir Phosphate	23	23
Vascepa	Icosapent Ethyl	23	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	23	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Fluconazole	Fluconazole	22	18
Tramadol Hcl	Tramadol Hcl	22	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Ondansetron Odt	Ondansetron	20	20
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	17
Acetazolamide	Acetazolamide	19	19
Alendronate Sodium	Alendronate Sodium	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	14
Meclizine Hcl	Meclizine Hcl	19	12
Mirtazapine	Mirtazapine	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Primidone	Primidone	18	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Moxifloxacin	Moxifloxacin Hcl	17	15
Victoza 2-Pak	Liraglutide	16	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Digoxin	Digoxin	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	11
Memantine Hcl	Memantine Hcl	15	suppressed
Tadalafil	Tadalafil	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Jardiance	Empagliflozin	14	suppressed
Clonazepam	Clonazepam	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	11
Nystatin	Nystatin	13	suppressed
Temazepam	Temazepam	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Victoza 3-Pak	Liraglutide	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Crestor	Rosuvastatin Calcium	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	12	suppressed
Humalog Mix 75-25	Insulin Lispro Protamin/Lispro	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Modafinil	Modafinil	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Cephalexin	Cephalexin	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error